You are here: Industry Insights > Merck

News List

FDA approves Samsung/Merck & Co’s Herceptin biosimilar pharmaphorum
January 23, 2019
The FDA has approved a new biosimilar of Roche’s breast cancer drug Herceptin, from Samsung Bioepis and Merck & Co, ahead of the original drug’s US patent expiry in June.
Merck bumps Keytruda credibility with real doctor appearance in latest ‘Tru’ patient ads fiercepharma
January 17, 2019
Merck & Co. is changing the game again in oncology ads, this time putting a real doctor to work in its Keytruda patient campaign. The latest additions to the multichannel "It's Tru" work include two TV ads, one with oncologist Goetz Kloecker, M.D., alone
Merck, Roche to renew global distribution agreement biospectrumasia
January 16, 2019
Global distribution agreement renewed under existing terms for additional five years
Merck's Keytruda slashes death risk by 31% in esophageal cancer victory fiercepharma
January 15, 2019
Back in November, Merck & Co. said its immuno-oncology star, Keytruda, had topped chemo at lengthening the lives of some esophageal cancer patients. Monday, it showed that the win was a sizable one.
Pharma nears landmark win as Supreme Court leans toward Merck's Fosamax defense fiercepharma
January 10, 2019
The Supreme Court case brought by hundreds of Fosamax patients against Merck & Co. seems to be going the drugmaker’s way, potentially upholding the popular preemption argument the pharma industry has used to fight product liability suits.
Pharma nears landmark win as Supreme Court leans toward Merck's Fosamax defense fiercepharma
January 10, 2019
The Supreme Court case brought by hundreds of Fosamax patients against Merck & Co. seems to be going the drugmaker’s way, potentially upholding the popular preemption argument the pharma industry has used to fight product liability suits.
Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles fiercepharma
January 10, 2019
Monday was a good-news-bad-news day for Gilead Sciences at the U.S. Supreme Court, with the justices handing down multiple decisions about which appeals they would take up as they headed back to work after the holiday break.
Merck's cancer aims, Gilead's new CEO; Pfizer's cliff-free future fiercepharma
January 09, 2019
Pharma came storming out of the gate at this year's J.P. Morgan Healthcare Conference in a Monday full of deal talk, CEO ambitions and analyst assessments and prognostications.
Why hasn't Merck been making deals? It's not for lack of trying, CEO says fiercepharma
January 09, 2019
“We’re very active,” CEO Ken Frazier said during a Monday afternoon fireside chat at the J.P. Morgan Healthcare Conference, adding “the fact that you haven’t seen a large deal coming out of Merck recently is not reflective of the fact that we’re not looki
Merck loses bid to revive $200 million Gilead verdict at US high court expressbpd
January 09, 2019
Merck had urged the Supreme Court to place limits on the doctrine of ‘unclean hands’ that can prevent plaintiffs from winning lawsuits if they acted in bad faith.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page